654 related articles for article (PubMed ID: 34381196)
1. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.
Wang D; Day EA; Townsend LK; Djordjevic D; Jørgensen SB; Steinberg GR
Nat Rev Endocrinol; 2021 Oct; 17(10):592-607. PubMed ID: 34381196
[TBL] [Abstract][Full Text] [Related]
2. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Breit SN; Brown DA; Tsai VW
Annu Rev Physiol; 2021 Feb; 83():127-151. PubMed ID: 33228454
[TBL] [Abstract][Full Text] [Related]
3. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.
Klein AB; Nicolaisen TS; Johann K; Fritzen AM; Mathiesen CV; Gil C; Pilmark NS; Karstoft K; Blond MB; Quist JS; Seeley RJ; Færch K; Lund J; Kleinert M; Clemmensen C
Cell Rep; 2022 Aug; 40(8):111258. PubMed ID: 36001956
[TBL] [Abstract][Full Text] [Related]
4. The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.
Tsai VWW; Husaini Y; Sainsbury A; Brown DA; Breit SN
Cell Metab; 2018 Sep; 28(3):353-368. PubMed ID: 30184485
[TBL] [Abstract][Full Text] [Related]
5. GDF15: A Hormone Conveying Somatic Distress to the Brain.
Lockhart SM; Saudek V; O'Rahilly S
Endocr Rev; 2020 Aug; 41(4):. PubMed ID: 32310257
[TBL] [Abstract][Full Text] [Related]
6. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
[TBL] [Abstract][Full Text] [Related]
7. Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Nadwa EH; Albogami SM; Alorabi M; Saad HM; Batiha GE
J Diabetes; 2022 Dec; 14(12):806-814. PubMed ID: 36444166
[TBL] [Abstract][Full Text] [Related]
8. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond.
Mullican SE; Rangwala SM
Trends Endocrinol Metab; 2018 Aug; 29(8):560-570. PubMed ID: 29866502
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study.
Cheung CL; Tan KCB; Au PCM; Li GHY; Cheung BMY
EBioMedicine; 2019 Mar; 41():85-90. PubMed ID: 30772304
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.
Siddiqui JA; Pothuraju R; Khan P; Sharma G; Muniyan S; Seshacharyulu P; Jain M; Nasser MW; Batra SK
Cytokine Growth Factor Rev; 2022 Apr; 64():71-83. PubMed ID: 34836750
[TBL] [Abstract][Full Text] [Related]
11. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss.
Day EA; Ford RJ; Smith BK; Mohammadi-Shemirani P; Morrow MR; Gutgesell RM; Lu R; Raphenya AR; Kabiri M; McArthur AG; McInnes N; Hess S; Paré G; Gerstein HC; Steinberg GR
Nat Metab; 2019 Dec; 1(12):1202-1208. PubMed ID: 32694673
[TBL] [Abstract][Full Text] [Related]
12. Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.
Guo X; Asthana P; Zhai L; Cheng KW; Gurung S; Huang J; Wu J; Zhang Y; Mahato AK; Saarma M; Ustav M; Kwan HY; Lyu A; Chan KM; Xu P; Bian ZX; Wong HLX
Nat Commun; 2024 Feb; 15(1):1034. PubMed ID: 38310105
[TBL] [Abstract][Full Text] [Related]
13. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.
Breit SN; Tsai VW; Brown DA
Trends Mol Med; 2017 Dec; 23(12):1065-1067. PubMed ID: 29129392
[TBL] [Abstract][Full Text] [Related]
14. GDF15 mediates the effects of metformin on body weight and energy balance.
Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
[TBL] [Abstract][Full Text] [Related]
15. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
[TBL] [Abstract][Full Text] [Related]
16. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
[TBL] [Abstract][Full Text] [Related]
17. Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
Kanta JM; Deisen L; Johann K; Holm S; Lundsgaard A; Lund J; Jähnert M; Schürmann A; Clemmensen C; Kiens B; Fritzen AM; Kleinert M
Mol Metab; 2023 Aug; 74():101760. PubMed ID: 37356805
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases.
Baek SJ; Eling T
Pharmacol Ther; 2019 Jun; 198():46-58. PubMed ID: 30790643
[TBL] [Abstract][Full Text] [Related]
19. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight.
Zhang SY; Bruce K; Danaei Z; Li RJW; Barros DR; Kuah R; Lim YM; Mariani LH; Cherney DZ; Chiu JFM; Reich HN; Lam TKT
Cell Metab; 2023 May; 35(5):875-886.e5. PubMed ID: 37060902
[TBL] [Abstract][Full Text] [Related]
20. Identification of GDF15 peptide fragments inhibiting GFRAL receptor signaling.
Alexopoulou F; Buch-Månson N; Pedersen SL; Vrang N; Fink LN; Strømgaard K
Peptides; 2023 Oct; 168():171063. PubMed ID: 37495041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
